Access Statistics for Diego Useche

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 0 0 0 0 0 3 33
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 0 0 0 0 1 1 2 12
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 0 20
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 1 1 8
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 1 11
Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation 0 0 0 0 0 0 2 33
Empirical economic analysis of orphan drug legislation impact on innovation 0 0 0 0 0 0 0 416
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 0 0 3 18
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 0 0 2 15
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 0 0 1 12
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 0 0 4
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 1 2 5
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 0 2 28
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 48 0 2 3 89
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 16 0 0 2 117
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021 0 0 0 0 0 0 0 8
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies 0 0 0 0 0 0 0 18
Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies 0 0 0 0 0 0 3 46
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 0 0 0 7 0 0 1 19
Total Working Papers 0 0 0 71 1 5 28 912


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 1 1 44 1 5 8 166
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 0 1 2 8 0 6 18 51
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 1 23 0 0 3 94
Patenting Behaviour and the Survival of Newly Listed European Software Firms 0 0 0 8 0 0 2 37
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 0 0 1 8 1 2 5 32
Total Journal Articles 0 2 5 91 2 13 36 380


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 1 14 0 0 3 85
Total Chapters 0 0 1 14 0 0 3 85


Statistics updated 2025-07-04